The HCPLive Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.
November 22nd 2024
A study identified homelessness and minority status as factors that impact clozapine prescription patterns.
November 14th 2024
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
Pennsylvania Implements New Guidelines for Treating Pain in the Emergency Department
The guidelines were developed as part of a multi-part plan to curb misuse, abuse, and diversion of opioid medication by preventing opioid medications from being inappropriately prescribed in the emergency department, and by reducing the overuse of emergency departments for pain relief.
Steps for Primary Care Providers to Improve Opioid Prescribing for Chronic Pain
One of the most common treatment courses for chronic pain is comprised of prescription opioid medications. However, concerns about drug addiction and abuse oftentimes outweigh the drugs' pain-relieving benefits.
Recovery Trajectories for Short-stay Surgery Vary Considerably
July 22nd 2014Though hospital stay duration was once used as a surrogate outcome for surgical recovery, the increasing popularity of short-stay surgery has eliminated that measure, making it harder for hospitals to track recovery trajectories and more difficult for surgeons to plan physical, psychological, and social postoperative courses for prospective patients.
New Alzheimer's Disease Drug Produces Mixed Results in Clinical Studies
In an effort to help patients diagnosed with mild-to-moderate Alzheimer's disease, drug manufacturer Roche announced the results of a pair of clinical studies on its investigational medication, crenezumab.
To Answer Patient Questions, Physicians Turn to New Information Sources
July 14th 2014In a recent survey, physicians identified peer-reviewed journal articles, continuing medical education, evidence-based guidelines, and national experts as the most useful sources of information to stay current on therapeutic advances.